logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
21/11/2025
The 40-year Japanese government bond yield fell by 5.5 basis points to 3.690%.
Latest
3 m ago
Pfizer announced that the world's first innovative drug, Trazimab (generic name: emicizumab), which requires only a fixed dose subcutaneous injection once a week, has been officially approved by the China National Medical Products Administration for the routine prevention and treatment of heavy A-type hemophilia without factor VIII inhibitors or heavy B-type hemophilia without factor IX inhibitors in children and adults aged 12 years and older who weigh 35kg, to prevent bleeding or reduce the frequency of bleeding episodes.
5 m ago
The first fixed-dose subcutaneous injection of Pfizer's non-factor innovative therapy for hemophilia, Vyondys, has been approved in China.
5 m ago
Benefiting from the rapid development of multimodal applications, Futu Holdings (03738) has launched AI music detection services.
8 m ago
Three residential land plots in Guangzhou have been listed for sale, with a total starting price of 4.271 billion yuan.
8 m ago
Minister of Education Huai Jinping conducts a survey on the study abroad service center of the Ministry of Education.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.